Life/Health M&A Hit $54B in 2025 on 14 Megadeals: What Milliman's Report Means for Actuarial Consulting Pipelines

Milliman's Life and Health Insurance M&A: A Review of 2025 and an Outlook, published April 7, 2026, records publicly announced deal value up 150% to approximately $53.9 billion while the global transaction count held flat at 85.

The whole of that increase sits in one place. Fourteen transactions crossed the billion-dollar threshold in 2025, against four in 2024, and the value growth is almost entirely megadeal concentration rather than a broader market.

Key Takeaways

• 14 megadeals against 4 the prior year carried deal value from roughly $21.6 billion to $53.9 billion on an unchanged 85 transactions, so average deal size, not deal flow, is what moved.
• Europe went from $3.0 billion to $33.6 billion, past its previous record of $15.6 billion set in 2021, on seven megadeals including the $11.6 billion Helvetia-Baloise merger and the EUR 3.5 billion Viridium consortium.
• $85 billion of reserves across more than four million policies came with Nippon Life's $10.6 billion Resolution Life acquisition, which is the unit that determines the appraisal workload rather than the headline price.
• Asia's deal count fell 15% to 22 while value rose 119% to $5.8 billion, a shift toward partial stake acquisitions rather than full buyouts.
• Roughly 75% of insurers now hold private assets and 91% plan to increase those allocations, which is where the return assumptions in these appraisals are hardest to validate.

Where the $53.9 Billion Came From

The value surge is a small number of very large transactions, and each carries a different strategic logic.

The largest was the merger of Swiss insurers Helvetia and Baloise, announced in April 2025 and completed in December, at approximately $11.6 billion. It created the second largest Swiss group with around 20% combined domestic market share, more than 22,000 employees, and CHF 20.1 billion of total premiums split CHF 8.6 billion life and CHF 11.5 billion non-life, at an exchange ratio of 1.0119 new Helvetia shares per Baloise share and CHF 350 million of expected pre-tax cost synergies.

Nippon Life's $10.6 billion purchase of Resolution Life, completed in October 2025, was the largest overseas acquisition by a Japanese insurer on record. Nippon had held 23% since 2019 and paid $8.2 billion to $8.4 billion for the remaining stake. Aquarian Capital agreed to acquire Brighthouse Financial for $4.1 billion, all cash at $70 per share, a premium of roughly 35%, against 2025 annuity production of $10.3 billion. A consortium of Allianz, BlackRock, Generali Financial Holdings, Hannover Re and T&D United Capital took Viridium from Cinven for EUR 3.5 billion, a platform with roughly 5% German market share, EUR 67 billion of assets under management and 3.4 million policyholders.

The concentration is not confined to life and health. Across all insurance lines PwC counted seven megadeals worth $29.6 billion in the second half of 2025 alone, 3% of deal volume and 93% of deal value.

Reserve Scale, Not Deal Count, Sets the Work

The distinction that matters for actuarial capacity is that appraisal effort tracks the size and complexity of the in-force book rather than the number of transactions, and 2025 moved sharply on the first while leaving the second flat.

Europe supplies the clearest case. Value rose from $3.0 billion to $33.6 billion, driven by the Danish Compromise, now permanent, which lets banks apply a lower risk weight to insurance subsidiaries and so changes bancassurance deal economics. Valuing an insurance subsidiary inside a banking group capital framework means working where Solvency II and Basel III intersect, which is a different exercise from a standalone appraisal on the same book.

North America's 28 deals held value near $14.4 billion, with five over $1 billion, but the composition shifted toward Japanese buyers: Dai-ichi Life took roughly 15% of London-listed M&G to become its largest single shareholder and is reported to be weighing a doubling of its overseas investment target to JPY 600 billion.

Resolution Life is the illustration of the scale point. Its $85 billion of reserves across more than four million policies has to be validated assumption by assumption, reconciling JGAAP and U.S. statutory reserve methodology, with currency risk modeled on the liability side and investment assumptions tested on a portfolio weighted toward private credit with Blackstone continuing as manager.

Mortality improvement scales, lapse and surrender curves, expense loadings, reinvestment paths and dynamic policyholder behavior each get an independent view. In the U.S. that now runs concurrently under LDTI for GAAP and principle-based reserving under VM-20 and VM-21, with the AG 55 framework adding asset adequacy testing wherever offshore reinsurance structures are involved.

The Asset Side Is the Harder Half

The constraint on all of this is that the liabilities being acquired are increasingly backed by assets that do not price themselves.

Roughly 75% of insurers now hold private assets and 91% plan to increase private market allocations over the next two years. Validating a return assumption on an illiquid class with limited mark-to-market data is a different exercise from fixed income analysis, and it is precisely the input a private equity backed acquirer's economics depend on.

Apollo's Athene platform manages approximately $274 billion, around 50% of Apollo's $548 billion total; KKR's Global Atlantic, bought in 2020 for $4.4 billion, has taken insurance AUM from $26 billion to more than $96 billion. Higher investment return targets feed straight into reserve discount rates and product pricing, which is why the NAIC's work on affiliated reinsurance and complex asset-backed reserves sits directly on top of this deal cycle.

The adjacent markets compete for the same review capacity rather than relieving it. S&P Global estimates more than $100 billion of closed block reinsurance closed in the U.S. in 2025, led by Venerable Holdings taking $51 billion of variable annuities from Corebridge Financial for approximately $2.8 billion. Athene's eighth block transaction, covering Sony Life's USD-denominated whole life policies, brought its cumulative Japanese cedant volume to roughly $19 billion. Pension risk transfer ran at an estimated $45 billion to $50 billion, with a record 94% of de-risking sponsors intending to divest liabilities fully and the active insurer count now above 20, a market the Brookfield-Just Group acquisition is consolidating in turn.

A single $51 billion variable annuity block carries pricing analysis, hedging review and reserve adequacy testing on a scale that rivals a traditional deal. Counting fourteen megadeals understates what is actually queued.